Print Friendly
(NEW YORK, NY – May 1, 2009) — MBL Communications, Inc. announced today the appointment of Andrew A. Nierenberg, MD, as Editor-in-Chief of CNS Spectrums effective May 1, 2009.
With the largest monthly circulation among scientifically indexed, peer-reviewed neuropsychiatric journals in the United States, CNS Spectrums’ editorial direction and development will be lead by Dr. Nierenberg, in conjunction with the editorial advisory board and international editors, in an enhanced effort to attract the highest quality papers covering the full spectrum of psychiatric and neuropsychiatric issues—with a special emphasis on critical reviews and informative clinical trials.
Recognized internationally for his specific area of interest focusing on patient-oriented, clinical research on depression and bipolar disorder, Dr. Nierenberg is currently Professor of Psychiatry at Harvard Medical School, Co-Director of the Bipolar Clinic and Research Program, and Associate Director of the Depression Clinical and Research Program at Massachusetts General Hospital (MGH) in Boston. Dr. Nierenberg received his M.D. from Albert Einstein College of Medicine of Yeshiva University followed by a Robert Wood Johnson Clinical Scholar fellowship in clinical epidemiology at Yale University.
Prior to joining the staff at MGH, Dr. Nierenberg was Director of a mood disorders research inpatient unit and the founder and Director of the Treatment Resistant Depression Program at McLean Hospital from 1986 to 1992. He then joined the Massachusetts General Hospital in 1992 and in 2007 he became the Co-Director of the Bipolar Program.
“I am delighted to become the Editor-in-Chief of CNS Spectrums,” Dr. Nierenberg said. “CNS Spectrums provides an important forum to disseminate research findings and integrative reviews to practicing clinicians interested in psychiatry and neuropsychiatry. We have a terrific team that is dedicated to publishing high quality, high impact papers consistent with the highest ethical principles. I look forward to collaborating with the international editors and newly constituted editorial board, as well as MBL Communications and its staff.”
In conjunction with Dr. Nierenberg’s appointment, CNS Spectrums will also modify its existing peer review process into a fully electronic, web-based e-peer review program based on the Scholar One\MS Central platform. This will streamline the journal’s overall publication structure and improve both the time from manuscript submission to acceptance and acceptance to publication.
“On behalf of the entire company, we are more than thrilled to have Dr. Nierenberg grasp the helm of CNS Spectrums as we soon enter our 15th year of continuous publication, and extremely confident his strong background in clinical research, coupled with his profound drive for editorial excellence and integrity, will enable us to successfully build upon the journal’s solid foundation for years to come,” noted CEO, Darren L. Brodeur.
About MBL Communications, INC.
MBL Communications, Inc. is a leading independent, CNS-based publishing and communications company founded in New York City in 1994. For more information, please visit www.mblcommunications.com. MBL’s core properties include:
Primary Psychiatry – The Largest Peer Reviewed Psychiatric Journal in the Nation – which has the largest US circulation among peer-reviewed psychiatry journals with a monthly readership of 65,500 primary care physicians and psychiatrists. For more information, please visit www.primarypsychiatry.com
CNS Spectrums – The International Journal of Neuropsychiatric Medicine – which has the largest circulation in the US among peer-reviewed, scientifically indexed neuropsychiatry journals with a monthly readership of 48,500 psychiatrists and neurologists. For more information, please visit www.cnsspectrums.com
Psychiatry Weekly – The first weekly psychiatric news and information service in the country delivered via wallboard format – which is distributed to psychiatrists and other mental health professionals through 630 domestic psychiatric hospitals and institutions. For more information, please visit www.psychiatryweekly.com